[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)

Global Statistics Representing Anti-Acne Treatment Market Scenario

Acne is a long-lasting inflammatory skin condition that creates pimples and spots, especially on sensitive areas such as the face, neck, shoulders, upper arms, back and chest. In the next few years, the anti-acne treatment market is projected to witness a substantial growth due to the increasing prevalence of acne across the globe. The condition affects at least 3 in every 4 persons aged 11 to 30 years. Moreover, the rapidly developing medical industry has lifted the market to some extent as more people are shifting their preferences towards lightweight, anti-acne cosmetic options.

The anti-acne treatment market was valued at USD 5.5 billion in 2018 and is expected to grow at a CAGR of 4.3% during the forecast period 2019–2026.

Increasing Investment for the Development of Advanced Therapies

Despite the significant availability of treatment options, acne remains an area of significant unmet medical need as treatment. However, increasing investment in developing innovative therapeutics is further driving the market growth.

Some of them are listed below:

  • In January 2019: Vyome Therapeutics Inc. invested around USD 22 million for the development of its lead molecule, VB 1953, which is in phase two clinical trial
  • In February 2019: S-Biomedic and SkinBioTherapeutics raised around USD 6 million for the development of acne treatment
  • In August 2019: Cassiopea SpA, submitted a New Drug Application (NDA) to the FDA for its clascoterone cream 1%

Market Dynamics

Some of the major factors driving the market growth are increasing concern and stress in the work environment, rising environmental pollution, changing lifestyle, increasing disposable income, and growing awareness regarding acne treatments and products. As per the Journal of American Academy of Dermatology (AAD), around 54% of women aged 25 and older are suffering from facial acne, which is further boosting the demand for anti-acne treatment in the developed and developing regions.

Regional Insights

Geographically, the global anti-acne treatment market is segmented into North America, Europe, Asia Pacific, and Latin America and the Middle East & Africa (LAMEA).

North America holds one of the largest shares of the anti-acne treatment market and is likely to continue the same during the forecast period. Rising incidences of acne problems and growing awareness about available medications are some of the factors driving the market growth. In the U.S., acne is one of the most prevalent skin condition affecting around 50 million Americans annually, which is subsequently boosting the demand for hyaluronic acid and retinoids in skincare products as they possess anti-aging and anti-acne properties. Some of the famous brands offering retinoids-based skincare products are Vichy, SkinMedica, and Dr. Dennis Gross, Skinceuticals, among others.

Europe is second in the global anti-acne treatment market due to highly prevalent acne issues among teenagers. According to the British Skin Foundation, about 95% of acne sufferers are experiencing a lack of self-confidence, consciousness, and various other issues, which is projected to boost the market growth to some extent.

Asia Pacific is projected to emerge as one of the fastest-growing anti-acne treatment markets. This can be attributed to the increasing expenses on beauty products, growing awareness about aesthetic procedures, rising tourism, and increasing penetration of online portals. In Korea, the geographical proximity of Korean cosmetics is facilitating cross border e-commerce in Asia. Additionally, the demand for natural products from hospitality and spa sectors are offering new growth avenues for the anti-acne treatment market.

Shift in Industry

Nowadays, consumers are paying more attention to ingredients in all the skincare products, when it comes to sensitive acne-prone skins, preferring natural, and organic products over those that contain ingredients or chemicals that could cause side effects. Moreover, increasing prevalence of stress and environmental pollution, and growing concerns among the youth regarding their looks is boosting the market growth.

Psych-dermatology is the new treatment technology. Here, the psychiatrists work with dermatologists to treat skin conditions by handling the causes of stress. The technique is gaining traction due to increasing emotional breakdown and low self-confidence. Many private and NHS hospitals such as The London School of Medicine and Dentistry, London’s Royal Free Hospital, and Bart’s have started establishing such clinics.

Other treatment options include Kleresca Acne Treatment, which uses BioPhotonics for the treatment of acne. It is a unique light conversion system that helps in reducing scarring and acne. The treatment includes the use of a high-intensity light device with a photo converter gel for killing the bacteria.

Key Players

Some of the key players in the anti-acne treatment market are Allergan plc. (Ireland), Valeant Pharmaceutical International Inc. (U.S), Johnson & Johnson Private Limited (U.S), Galderma S.A (Switzerland), Stiefel Laboratories, Inc. (U.S), GlaxoSmithKline (UK), Teva Pharmaceutical Industries (Israel), Bayer AG (Germany), and Roche Holding AG (Switzerland).

Anti-Acne Treatment Market Segmentation

By Products

  • Antibiotics
  • Retinoid Therapy
  • Hormonal Drugs
  • Chemical Peels
  • Others

By Type

  • Inflammatory
  • Non-Inflammatory

By Therapy

  • Oral
  • Topical
  • Others

By Region

North America

    • U.S.
    • Canada
    • Mexico

Europe

    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe

Asia-Pacific

    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific

LAMEA

    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Frequently Asked Questions (FAQs)

The Anti-Acne Treatment Market was valued at USD 5.5 billion in 2018 and is expected to grow at a CAGR of 4.3% during the forecast period 2019–2026.
Increasing concern and stress in the work environment, rising environmental pollution, changing lifestyle, increasing disposable income, and growing awareness regarding acne treatments and products are the key factor expected to drive the Anti-Acne Treatment Market during the forecast period.
North America is expected to hold the highest market share in Anti-Acne Treatment Market.
In 2018 Global Anti-Acne Treatment Market was valued at USD 5.5 billion.
Allergan plc. Valeant Pharmaceutical International Inc., Johnson & Johnson Private Limited, Galderma S.A, Stiefel Laboratories, Inc., GlaxoSmithKline are the top players in Anti-Acne Treatment Market.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.


Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports